These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


82 related items for PubMed ID: 6499931

  • 1. A dopamine D2 receptor photolabel: azidoclebopride.
    Niznik HB, Guan JH, Neumeyer JL, Seeman P.
    Eur J Pharmacol; 1984 Sep 17; 104(3-4):389-90. PubMed ID: 6499931
    [No Abstract] [Full Text] [Related]

  • 2. A photoaffinity ligand for dopamine D2 receptors: azidoclebopride.
    Niznik HB, Guan JH, Neumeyer JL, Seeman P.
    Mol Pharmacol; 1985 Feb 17; 27(2):193-9. PubMed ID: 3969068
    [Abstract] [Full Text] [Related]

  • 3. Photoaffinity labeling of human brain dopamine receptors.
    Wouters W, Van Dun J, Laduron PM.
    Biochem Pharmacol; 1984 Nov 01; 33(21):3517-20. PubMed ID: 6548631
    [No Abstract] [Full Text] [Related]

  • 4. Photoaffinity labelling of dopamine D2 receptors by [3H]azidomethylspiperone.
    Niznik HB, Grigoriadis DE, Seeman P.
    FEBS Lett; 1986 Dec 01; 209(1):71-6. PubMed ID: 2948835
    [Abstract] [Full Text] [Related]

  • 5. Dopamine D2 receptor dissociation constant for spiperone: identical values using 3H-labeled agonist or 3H-labeled antagonist.
    Seeman P, Grigoriadis D.
    Biochem Pharmacol; 1985 Nov 15; 34(22):4065-6. PubMed ID: 4062976
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Selective labelling of dopamine (D2) receptors in rat striatum by [3H]domperidone but not by [3H]spiperone.
    Lazareno S, Nahorski SR.
    Eur J Pharmacol; 1982 Jul 09; 81(2):273-85. PubMed ID: 7117377
    [Abstract] [Full Text] [Related]

  • 10. Photoaffinity labelling of dopamine receptors. Synthesis and binding characteristics of azapride.
    Wouters W, Van Dun J, Laduron PM.
    Eur J Biochem; 1984 Dec 03; 145(2):273-8. PubMed ID: 6548707
    [Abstract] [Full Text] [Related]

  • 11. Novel photoaffinity label for the dopamine D2 receptor: synthesis of 4-azido-5-iodo-2-methoxy-N-[1-(phenylmethyl)-4-piperidinyl] benzamide (iodoazidoclebopride, IAC) and the corresponding 125I-labeled analogue (125IAC).
    Neumeyer JL, Guan JH, Niznik HB, Dumbrille-Ross A, Seeman P, Padmanabhan S, Elmaleh DR.
    J Med Chem; 1985 Apr 03; 28(4):405-7. PubMed ID: 3156993
    [No Abstract] [Full Text] [Related]

  • 12. Synthesis and binding properties of the fluorinated substituted benzamide [3H]NCQ 115, a new selective dopamine D2 receptor ligand.
    Hall H, Högberg T, Halldin C, Bengtsson S, Wedel I.
    Eur J Pharmacol; 1991 Aug 16; 201(1):1-10. PubMed ID: 1686586
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. In vivo [3H]spiperone binding: evidence for accumulation in corpus striatum by agonist-mediated receptor internalization.
    Chugani DC, Ackermann RF, Phelps ME.
    J Cereb Blood Flow Metab; 1988 Jun 16; 8(3):291-303. PubMed ID: 2966803
    [Abstract] [Full Text] [Related]

  • 16. Magnesium ions reveal nanomolar potency of dopamine at [3H]spiperone labelled D-2 receptors in rat corpus striatum.
    De Vries DJ, Beart PM.
    Eur J Pharmacol; 1985 Mar 12; 109(3):417-9. PubMed ID: 3157589
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Preparation of an affinity chromatography matrix for the selective purification of the dopamine D2 receptor from bovine striatal membranes.
    Clagett-Dame M, Schoenleber R, Chung C, McKelvy JF.
    Biochim Biophys Acta; 1989 Nov 27; 986(2):271-80. PubMed ID: 2531613
    [Abstract] [Full Text] [Related]

  • 20. Antipeptide antibodies localize N-(4-azido-3-[125I] iodophenethyl)spiperone binding to the carboxyl-terminal portion of the D2 dopamine receptor.
    David C, Fuchs S.
    Mol Pharmacol; 1991 Nov 27; 40(5):712-6. PubMed ID: 1834930
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.